No let-up in Spain for pharma as austerity measures keep on coming
This article was originally published in SRA
Executive Summary
There have already been price cuts for branded drugs and pro-generic prescribing measures. Even more radical change is in store as the Spanish government prepares the way for introducing, among other things, value-based pricing for new drugs, reports Esther Minguell.